Clinical Trial Update: Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS) [NA]

View source ↗

Summary

A completed clinical trial evaluating continuous glucose monitoring for high-risk hospitalized adults with Type 2 diabetes (Cyber GEMS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Scripps Whittier Diabetes Institute | Conditions: Type 2 Diabetes | NA | Status: COMPLETED